Remedium Capital Partners, LLC
6 holdingsFiling period: 2026-03-31Current AUM: $545.2Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | SYRE | Spyre Therapeutics Inc | 1.91M | $96.2M | $187.5M | 34.40% | +451.1K | 2026-03-31 |
| 2 | ORKA | Oruka Therapeutics Inc | 1.89M | $92.7M | $182.3M | 33.44% | +336.7K | 2026-03-31 |
| 3 | DMRA | Damora Therapeutics Inc | 2.05M | $53.0M | $59.3M | 10.88% | +1.93M | 2026-03-31 |
| 4 | APGE | Apogee Therapeutics Inc | 583.6K | $49.1M | $78.3M | 14.35% | -- | 2026-03-31 |
| 5 | JBIO | Jade Biosciences Inc | 1.58M | $22.2M | $31.2M | 5.72% | -- | 2026-03-31 |
| 6 | GLYC | Crescent Biopharma Inc | 361.3K | $6.6M | $6.6M | 1.22% | -- | 2026-03-31 |
← Scroll →